Literature DB >> 25421174

Ring chromosomes, breakpoint clusters, and neocentromeres in sarcomas.

Gemma Macchia1, Karolin H Nord, Monica Zoli, Stefania Purgato, Pietro D'Addabbo, Christopher W Whelan, Lucia Carbone, Giovanni Perini, Fredrik Mertens, Mariano Rocchi, Clelia Tiziana Storlazzi.   

Abstract

Gene amplification is relatively common in tumors. In certain subtypes of sarcoma, it often occurs in the form of ring and/or giant rod-shaped marker (RGM) chromosomes whose mitotic stability is frequently rescued by ectopic novel centromeres (neocentromeres). Little is known about the origin and structure of these RGM chromosomes, including how they arise, their internal organization, and which sequences underlie the neocentromeres. To address these questions, 42 sarcomas with RGM chromosomes were investigated to detect regions prone to double strand breaks and possible functional or structural constraints driving the amplification process. We found nine breakpoint cluster regions potentially involved in the genesis of RGM chromosomes, which turned out to be significantly enriched in poly-pyrimidine traits. Some of the clusters were located close to genes already known to be relevant for sarcomas, thus indicating a potential functional constraint, while others mapped to transcriptionally inactive chromatin domains enriched in heterochromatic sites. Of note, five neocentromeres were identified after analyzing 13 of the cases by fluorescent in situ hybridization. ChIP-on-chip analysis with antibodies against the centromeric protein CENP-A showed that they were a patchwork of small genomic segments derived from different chromosomes, likely joint to form a contiguous sequence during the amplification process.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25421174     DOI: 10.1002/gcc.22228

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  The Hidden Genomic and Transcriptomic Plasticity of Giant Marker Chromosomes in Cancer.

Authors:  Gemma Macchia; Marco Severgnini; Stefania Purgato; Doron Tolomeo; Hilen Casciaro; Ingrid Cifola; Alberto L'Abbate; Anna Loverro; Orazio Palumbo; Massimo Carella; Laurence Bianchini; Giovanni Perini; Gianluca De Bellis; Fredrik Mertens; Mariano Rocchi; Clelia Tiziana Storlazzi
Journal:  Genetics       Date:  2017-12-26       Impact factor: 4.562

Review 2.  Genetic and epigenetic effects on centromere establishment.

Authors:  Yick Hin Ling; Zhongyang Lin; Karen Wing Yee Yuen
Journal:  Chromosoma       Date:  2019-11-28       Impact factor: 4.316

3.  MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences.

Authors:  Alberto L Abbate; Doron Tolomeo; Ingrid Cifola; Marco Severgnini; Antonella Turchiano; Bartolomeo Augello; Gabriella Squeo; Pietro D Addabbo; Debora Traversa; Giulia Daniele; Angelo Lonoce; Mariella Pafundi; Massimo Carella; Orazio Palumbo; Anna Dolnik; Dominique Muehlematter; Jacqueline Schoumans; Nadine Van Roy; Gianluca De Bellis; Giovanni Martinelli; Giuseppe Merla; Lars Bullinger; Claudia Haferlach; Clelia Tiziana Storlazzi
Journal:  Leukemia       Date:  2018-02-22       Impact factor: 11.528

4.  Detailed molecular cytogenetic characterisation of the myeloid cell line U937 reveals the fate of homologous chromosomes and shows that centromere capture is a feature of genome instability.

Authors:  Ruth N MacKinnon; Joanne Peverall; Lynda J Campbell; Meaghan Wall
Journal:  Mol Cytogenet       Date:  2020-12-14       Impact factor: 2.009

5.  BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features.

Authors:  Doron Tolomeo; Antonio Agostini; Gemma Macchia; Alberto L'Abbate; Marco Severgnini; Ingrid Cifola; Maria Antonia Frassanito; Vito Racanelli; Antonio Giovanni Solimando; Felix Haglund; Fredrik Mertens; Clelia Tiziana Storlazzi
Journal:  Hum Cell       Date:  2020-08-27       Impact factor: 4.174

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.